Jain Pooja, Marchant Tom, Green Melanie, Watkins Gillian, Davies Julie, McCarthy Claire, Loncaster Juliette, Stewart Alan, Magee Brian, Moore Christopher, Price Pat
Academic Department of Radiation Oncology, The University of Manchester, Manchester M20 4BX, UK.
Radiother Oncol. 2009 Jan;90(1):93-8. doi: 10.1016/j.radonc.2008.10.010. Epub 2008 Nov 13.
Intensity-modulated radiotherapy (IMRT) can improve dose homogeneity within the breast planned target volume (PTV), but may be more susceptible to patient/organ motion than standard tangential radiotherapy (RT). We used daily cone-beam CT (CBCT) imaging to assess inter-fraction motion during breast IMRT and its subsequent impact on IMRT and standard RT dose homogeneity.
Ten breast cancer patients selected for IMRT were studied. CBCT images were acquired immediately after daily treatment. Automatic image co-registration was used to determine patient positioning variations. Daily PTV contours were used to calculate PTV variations and daily delivered IMRT and theoretically planned tangential RT dose.
Group systematic (and random) setup errors detected by CBCT were 5.7 (3.9)mm laterally, 2.8 (3.5)mm vertically and 2.3 (3.2)mm longitudinally. Rotations >2 degrees in any axis occurred on 53/106 (50%) occasions. Daily PTV volume varied up to 23%. IMRT dose homogeneity was superior at planning and throughout the treatment compared with standard RT (1.8% vs. 15.8% PTV received >105% planned mean dose), despite increased motion sensitivity.
CBCT revealed inadequacies of current patient positioning and verification procedures during breast RT and confirmed improved dose homogeneity using IMRT for the patients studied.
调强放疗(IMRT)可改善乳腺计划靶区(PTV)内的剂量均匀性,但与标准切线放疗(RT)相比,可能更容易受到患者/器官运动的影响。我们使用每日锥形束CT(CBCT)成像来评估乳腺IMRT期间分次间的运动及其对IMRT和标准RT剂量均匀性的后续影响。
对10例选择IMRT的乳腺癌患者进行研究。每日治疗后立即采集CBCT图像。使用自动图像配准来确定患者体位变化。每日PTV轮廓用于计算PTV变化以及每日给予的IMRT和理论上计划的切线RT剂量。
CBCT检测到的组系统(和随机)摆位误差在横向为5.7(3.9)mm,纵向为2.8(3.5)mm,前后方向为2.3(3.2)mm。在53/106(50%)的情况下,任一轴上的旋转大于2度。每日PTV体积变化高达23%。尽管运动敏感性增加,但与标准RT相比,IMRT在计划时和整个治疗过程中的剂量均匀性更好(接受>105%计划平均剂量的PTV为1.8%对15.8%)。
CBCT揭示了乳腺放疗期间当前患者体位和验证程序的不足之处,并证实了在所研究的患者中使用IMRT可改善剂量均匀性。